What Are Bioidentical Hormones?
The term “bioidentical hormones” refers to compounds that are chemically identical to the hormones naturally produced by the human body, such as estradiol, progesterone, and testosterone. These hormones gained significant attention in the 1990s, though their use in medicine dates back earlier.
Bioidentical hormones became popular as an alternative to synthetic and animal-derived hormones like those in the drug Prempro. Prempro combines conjugated equine estrogens (derived from the urine of pregnant mares) with medroxyprogesterone acetate, a synthetic progestin. These synthetic and animal-derived hormones differ structurally from endogenous human hormones, which impacts how they interact with hormone receptors in the body.
Why Bioidentical Hormones Are Different
The structural differences between bioidentical and synthetic hormones influence their effects on the body. Bioidentical hormones precisely mimic the molecular structure of the body’s natural hormones, allowing them to bind seamlessly to human hormone receptors. In contrast, synthetic hormones like medroxyprogesterone acetate or conjugated equine estrogens bind to receptors differently, potentially activating unintended pathways or producing side effects.
This receptor mismatch may explain why synthetic hormones have been associated with negative health outcomes. The Women’s Health Initiative (WHI) study in the early 2000s linked the use of synthetic HRT to an increased risk of breast cancer, cardiovascular events, and stroke. This led to widespread fear of HRT in general, even though the risks appear to be tied more closely to the use of non-bioidentical hormones.
A Contemporary Perspective on Menopause Hormone Therapy
In their article A Contemporary View of Menopause Hormone Therapy, Dr. Barbara Levy and Dr. James A. Simon highlight how hormone therapy has changed over the years. They discuss how the 2002 WHI study caused concern about the safety of hormone treatments—linking conjugated equine estrogens and synthetic progestins to higher risks of breast cancer and heart problems. Because of this, many doctors stopped prescribing hormone therapy, and fewer doctors were trained to manage menopause.
Dr. Levy and Dr. Simon explain that not all hormone therapies are the same. Bioidentical hormones, which are exact copies of the hormones made by the human body, may be safer than synthetic or animal-based hormones. The negative effects seen in the WHI study might be due to the specific types of hormones used rather than hormone therapy in general.
The authors also stress the importance of starting hormone therapy at the right time. Research shows that beginning treatment soon after menopause starts could lead to better results. This idea is called the “timing hypothesis,” which suggests that the timing of hormone therapy affects both its benefits and risks.
Benefits of Using Bioidentical Hormones
Bioidentical hormones are advantageous because they offer a closer mimicry of the body’s natural hormonal activity, which may reduce the risk of adverse effects. Studies have suggested that bioidentical progesterone has a safer profile compared to synthetic progestins regarding cardiovascular health and breast cancer risk. Estradiol, a bioidentical form of estrogen, has also been shown to provide more predictable and favorable effects on bone density, mood, and menopausal symptoms.
Patients using bioidentical hormones often report fewer side effects—such as bloating, mood swings, and breast tenderness—compared to synthetic alternatives. Furthermore, bioidentical hormones can be customized in compounding pharmacies to meet individual patient needs, offering flexibility in dosage and administration methods (e.g., creams, gels, patches, or pills).
References
- Holtorf, K. (2009). “The Bioidentical Hormone Debate.” Postgraduate Medicine, 121(1), 73-85.
- Rossouw, J. E., et al. (2002). “Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women.” JAMA, 288(3), 321-333.
- Prior, J. C. (2019). “Bioidentical Hormones for Menopause.” Therapeutic Advances in Endocrinology and Metabolism.
- Levy, B., & Simon, J. A. (2023). “A Contemporary View of Menopause Hormone Therapy.” PubMed.
